5 of the Most Hated Biotech Stocks on the Market: Are They Buys?

5 of the Most Hated Biotech Stocks on the Market: Are They Buys?

One of the best ways to measure how much a stock is hated is by looking at the percentage of the stock's float that's sold short. Short-sellers think so poorly of a stock that they're willing to put money on the line that its price will fall.

Five biotech stocks appear to have incurred a lot of hate based on their levels of short interest: Agios Pharmaceuticals (NASDAQ: AGIO), Insys Therapeutics (NASDAQ: INSY), Intercept Pharmaceuticals (NASDAQ: ICPT), Lexicon Pharmaceuticals (NASDAQ: LXRX), and Myriad Genetics (NASDAQ: MYGN). But are these hated stocks actually smart picks to buy right now?

Image source: Getty Images.

Continue reading

Source: Fool.com